New Key Statistics Module, Z-Score and F-Score
OTCPK:ACORQ Key Ratios
| Market Cap $ M | 0.91 |
| Enterprise Value $ M | 161.85 |
| P/E(ttm) | -- |
| PE Ratio without NRI | -- |
| Forward PE Ratio | -- |
| Price/Book | -- |
| Price/Sales | -- |
| Price/Free Cash Flow | -- |
| Price/Owner Earnings | -- |
| Payout Ratio % | -- |
| Revenue (TTM) $ M | 117.00 |
| EPS (TTM) $ | -203.83 |
| Beneish M-Score | -3.44 |
| 10-y EBITDA Growth Rate % | -- |
| 5-y EBITDA Growth Rate % | -- |
| y-y EBITDA Growth Rate % | -782.70 |
| EV-to-EBIT | -0.61 |
| EV-to-EBITDA | -0.70 |
| PEG | -- |
| Shares Outstanding M | 1.24 |
| Net Margin (%) | -214.95 |
| Operating Margin % | -19.78 |
| Pre-tax Margin (%) | -251.65 |
| Quick Ratio | 0.26 |
| Current Ratio | 0.33 |
| ROA % (ttm) | -78.52 |
| ROE % (ttm) | -906.61 |
| ROIC % (ttm) | -6.72 |
| Dividend Yield % | -- |
| Altman Z-Score | -23.97 |
ACORQ Number of Guru Trades
ACORQ Volume of Guru Trades
Gurus Latest Trades with OTCPK:ACORQ
You need a Premium membership or above to view this section.
Take a 7-Day Free Trial
No Available Data
OTCPK:ACORQ is held by these investors
You need a Premium membership or above to view this section.
Take a 7-Day Free Trial
No Available Data
Acorda Therapeutics Inc Insider Transactions
No Available Data
News about OTCPK:ACORQ
Total 0- 1
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers